![Daniel Swisher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Swisher
Director/Board Member at
CORCEPT THERAPEUTICS INCORPORATED
Net worth: 447 017 $ as of 30/05/2026
Profile
Mr. Daniel N. Swisher is a President & Chief Operating Officer at Jazz Pharmaceuticals Plc, a President & Chief Operating Officer at Jazz Pharmaceuticals, Inc., an Independent Director at Corcept Therapeutics, Inc. and a Chairman at Cerus Corp. He is on the Board of Directors at Corcept Therapeutics, Inc. Mr. Swisher was previously employed as a President, CEO, Secretary & Director by Sunesis Pharmaceuticals, Inc. and a Senior Vice President-Sales & Marketing by ALZA Corp. He received his undergraduate degree from Yale University and an MBA from Stanford Graduate School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CERUS CORPORATION 0.07% | 02/06/2025 | 147,045 ( 0.07% ) | 447 017 $ | 30/05/2026 |
| 20/05/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Daniel Swisher active positions
| Companies | Position | Start |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 17/06/2015 |
Former positions of Daniel Swisher
| Companies | Position | End |
|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Chief Executive Officer | 03/02/2026 |
| CERUS CORPORATION | Chairman | 15/06/2025 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 16/09/2024 |
| JAZZ PHARMACEUTICALS PLC | President | 30/09/2023 |
| VIRACTA THERAPEUTICS, INC. | Chief Executive Officer | 30/12/2017 |
Training of Daniel Swisher
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
69
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology Provides and develops pharmaceutical products | Health Technology |
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
- Stock Market
- Insiders
- Daniel Swisher
